{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:42:03Z","timestamp":1765888923707,"version":"3.41.2"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The contribution of the cellular immune response to the severity of coronavirus disease 2019 (COVID-19) is still uncertain because most evidence comes from patients receiving multiple drugs able to change immune function. Herein, we conducted a prospective cohort study and obtained blood samples from 128 unvaccinated healthy volunteers to examine the <jats:italic>in vitro<\/jats:italic> response pattern of CD4+ and CD8+ T cells and monocyte subsets to polyclonal stimuli, including anti-CD3, anti-CD28, poly I:C, severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) recombinant spike S1 protein, and lipopolysaccharide. Then, we started a six-month follow-up and registered 12 participants who got SARS-CoV-2 infection, from whom we retrospectively analyzed the basal immune response pattern of T cells and monocytes. Of the 12 participants infected, six participants developed mild COVID-19 with self-limiting symptoms such as fever, headache, and anosmia. Conversely, six other participants developed severe COVID-19 with pneumonia, respiratory distress, and hypoxia. Two severe COVID-19 cases required invasive mechanical ventilation. There were no differences between mild and severe cases for demographic, clinical, and biochemical baseline characteristics. In response to polyclonal stimuli, basal production of interleukin-2 (IL-2) and interferon (IFN-) gamma significantly decreased, and the programmed cell death protein 1 (PD-1) increased in CD4+ and CD8+ T cells from participants who posteriorly developed severe COVID-19 compared to mild cases. Likewise, CD14++CD16- classical and CD14+CD16+ non-classical monocytes lost their ability to produce IFN-alpha in response to polyclonal stimuli in participants who developed severe COVID-19 compared to mild cases. Of note, neither the total immunoglobulin G serum titers against the virus nor their neutralizing ability differed between mild and severe cases after a month of clinical recovery. In conclusion, using <jats:italic>in vitro<\/jats:italic> polyclonal stimuli, we found a basal immune response pattern associated with a predisposition to developing severe COVID-19, where high PD-1 expression and low IL-2 and IFN-gamma production in CD4+ and CD8+ T cells, and poor IFN-alpha expression in classical and non-classical monocytes are linked to disease worsening. Since antibody titers did not differ between mild and severe cases, these findings suggest cellular immunity may play a more crucial role than humoral immunity in preventing COVID-19 progression.<\/jats:p>","DOI":"10.3389\/fimmu.2022.897995","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T12:20:31Z","timestamp":1656937231000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["In Vitro Exposure of Primary Human T Cells and Monocytes to Polyclonal Stimuli Reveals a Basal Susceptibility to Display an Impaired Cellular Immune Response and Develop Severe COVID-19"],"prefix":"10.3389","volume":"13","author":[{"given":"Rebeca","family":"Viurcos-Sanabria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aar\u00f3n N.","family":"Manjarrez-Reyna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Solleiro-Villavicencio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma A.","family":"Rizo-T\u00e9llez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda A.","family":"M\u00e9ndez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Viurcos-Sanabria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacquelina","family":"Gonz\u00e1lez-Sanabria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Am\u00e9rica","family":"Arroyo-Valerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 D.","family":"Carrillo-Ru\u00edz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Gonz\u00e1lez-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose I.","family":"Le\u00f3n-Pedroza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal","family":"Flores-Mej\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Octavio","family":"Rodr\u00edguez-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galileo","family":"Escobedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"141\u201354","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26424","article-title":"Epidemiology of COVID-19: A Systematic Review and Meta-Analysis of Clinical Characteristics, Risk Factors, and Outcomes","volume":"93","author":"Li","year":"2021","journal-title":"J Med Virol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.04.006","article-title":"Risk Factors for Severity and Mortality in Adult COVID-19 Inpatients in Wuhan","volume":"146","author":"Li","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.06.064","article-title":"Coronavirus Disease (COVID-19): A Systematic Review and Meta-Analysis to Evaluate the Impact of Various Comorbidities on Serious Events","volume":"14","author":"Nandy","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4239\/WJD.V12.I7.1026","article-title":"Immunometabolic Bases of Type 2 Diabetes in the Severity of COVID-19","volume":"12","author":"Viurcos-Sanabria","year":"2021","journal-title":"World J Diabetes"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-020-09721-2","article-title":"A Survival Analysis of COVID-19 in the Mexican Population","volume":"20","author":"Salinas-Escudero","year":"2020","journal-title":"BMC Public Health"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa363","article-title":"Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China","volume":"222","author":"Chi","year":"2020","journal-title":"J Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.23812\/CONTI-E","article-title":"Induction of Pro-Inflammatory Cytokines (IL-1 and IL-6) and Lung Inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): Anti-Inflammatory Strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine Release Syndrome in Severe COVID-19: Interleukin-6 Receptor Antagonist Tocilizumab may be the Key to Reduce Mortality","volume":"55","author":"Zhang","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.603563\/BIBTEX","article-title":"Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients","volume":"12","author":"Ni","year":"2021","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137244","article-title":"Clinical and Immunological Features of Severe and Moderate Coronavirus Disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0401-3","article-title":"Elevated Exhaustion Levels and Reduced Functional Diversity of T Cells in Peripheral Blood may Predict Severe Progression in COVID-19 Patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1084\/JEM.192.7.1027","article-title":"Engagement of the PD-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J Exp Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/NATURE04444","article-title":"Restoring Function in Exhausted CD8 T Cells During Chronic Viral Infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc6027","article-title":"Impaired Type I Interferon Activity and Inflammatory Responses in Severe COVID-19 Patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Sci (80- )"},{"key":"B17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41591-020-01202-8","article-title":"Immune Determinants of COVID-19 Disease Presentation and Severity","volume":"27","author":"Brodin","year":"2021","journal-title":"Nat Med 2021 271"},{"key":"B18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4331\/WJBC.V11.I2.14","article-title":"Immunological Aspects of COVID-19: What do We Know","volume":"11","author":"Velikova","year":"2020","journal-title":"World J Biol Chem"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-0148-4","article-title":"Lymphopenia Predicts Disease Severity of COVID-19: A Descriptive and Predictive Study","volume":"5","author":"Tan","year":"2020","journal-title":"Signal Transduct Target Ther 2020 51"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.560330","article-title":"Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes","volume":"11","author":"Lombardi","year":"2019","journal-title":"Article"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-2636-4","article-title":"The Inhibition of IL-2\/IL-2R Gives Rise to CD8+ T Cell and Lymphocyte Decrease Through JAK1-STAT5 in Critical Patients With COVID-19 Pneumonia","volume":"11","author":"Shi","year":"2020","journal-title":"Cell Death Dis 2020 116"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab005","article-title":"Early Differences in Cytokine Production by Severity of Coronavirus Disease 2019","volume":"223","author":"Tjan","year":"2021","journal-title":"J Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/infdis\/jiab288","article-title":"Type I, II, and III Interferon Signatures Correspond to COVID-19 Disease Severity","volume":"224","author":"Kim","year":"2021","journal-title":"J\u00a0Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"197\u2013203","DOI":"10.1002\/1521-4141","article-title":"Deficiency of IL-2 or IL-6 Reduces Lymphocyte Proliferation, But Only IL-6 Deficiency Decreases the Contact Hypersensitivity Response","volume":"30","author":"Hope","year":"2000","journal-title":"Eur J Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ETM.2021.9658","article-title":"Recombinant Interleukin-2 Stimulates Lymphocyte Recovery in Patients With Severe COVID-19","volume":"21","author":"Zhu","year":"2021","journal-title":"Exp Ther Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1084\/JEM.20041463","article-title":"Interferon-\u03b3 Acts Directly on CD8+ T Cells to Increase Their Abundance During Virus Infection","volume":"201","author":"Whitmire","year":"2005","journal-title":"J Exp Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional Exhaustion of Antiviral Lymphocytes in COVID-19 Patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol 2020 175"},{"key":"B28","doi-asserted-by":"publisher","first-page":":198171","DOI":"10.1016\/J.VIRUSRES.2020.198171","article-title":"IFN-\u03b3 is an Independent Risk Factor Associated With Mortality in Patients With Moderate and Severe COVID-19 Infection","volume":"289","author":"Gadotti","year":"2020","journal-title":"Virus Res"},{"key":"B29","unstructured":"PD-1 and its Ligands are Important Immune Checkpoints in Cancer\n            DongY\n            SunQ\n            ZhangX\n          2017"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/BJH.17034","article-title":"Increased CD95 (Fas) and PD-1 Expression in Peripheral Blood T Lymphocytes in COVID-19 Patients","volume":"191","author":"Bellesi","year":"2020","journal-title":"Br J Haematol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/J.IMMUNI.2020.12.002","article-title":"PD-1-Expressing SARS-CoV-2-Specific CD8 + T Cells Are Not Exhausted, But Functional in Patients With COVID-19","volume":"54","author":"Rha","year":"2021","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41591-021-01643-9","article-title":"A Guide to Immunotherapy for COVID-19","volume":"28","author":"van de Veerdonk","year":"2022","journal-title":"Nat Med 2022 281"},{"key":"B33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/J.IJID.2020.09.1466","article-title":"COX2 Inhibition in the Treatment of COVID-19: Review of Literature to Propose Repositioning of Celecoxib for Randomized Controlled Studies","volume":"101","author":"Baghaki","year":"2020","journal-title":"Int J Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12865-015-0103-2\/FIGURES\/6","article-title":"Dexamethasone Enhances Programmed Cell Death 1 (PD-1) Expression During T Cell Activation: An Insight Into the Optimum Application of Glucocorticoids in Anti-Cancer Therapy","volume":"16","author":"Xing","year":"2015","journal-title":"BMC Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.670088","article-title":"Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell Immunotherapy","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2147\/ITT.S280706","article-title":"Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches","volume":"10","author":"Hasan","year":"2021","journal-title":"ImmunoTargets Ther"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1807836","DOI":"10.1080\/2162402X.2020.1807836","article-title":"Immune Responses During COVID-19 Infection","volume":"9","author":"Melenotte","year":"2020","journal-title":"Oncoimmunology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS19092821","article-title":"Monocytes and Macrophages as Viral Targets and Reservoirs","volume":"19","author":"Nikitina","year":"2018","journal-title":"Int J Mol Sci 2018 Vol 19 Page 2821"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/J.HUMIMM.2020.12.010","article-title":"Dynamic Changes in Monocytes Subsets in COVID-19 Patients","volume":"82","author":"Qin","year":"2021","journal-title":"Hum Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":":e0241097","DOI":"10.1371\/JOURNAL.PONE.0241097","article-title":"SARS-CoV-2 Infection Induces Mixed M1\/M2 Phenotype in Circulating Monocytes and Alterations in Both Dendritic Cell and Monocyte Subsets","volume":"15","author":"Matic","year":"2020","journal-title":"PloS One"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.665773","article-title":"Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19","volume":"12","author":"Chilunda","year":"2021","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/J.JACI.2011.05.033","article-title":"Innate Immune Defects Correlate With Failure of Antibody Responses to H1N1\/09 Vaccine in HIV-Infected Patients","volume":"128","author":"Pallikkuth","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.684014","article-title":"Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients","volume":"12","author":"Lafon","year":"2021","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/J.CMI.2021.03.010","article-title":"SARS-CoV-2 Specific T-Cell Immunity in COVID-19 Convalescent Patients and Unexposed Controls Measured by Ex Vivo ELISpot Assay","volume":"27","author":"Cassaniti","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-07235-0","article-title":"An Analysis COVID-19 in Mexico: A Prediction of Severity","volume":"37","author":"Mart\u00ednez-Mart\u00ednez","year":"2022","journal-title":"J Gen Intern Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.897995\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T12:20:36Z","timestamp":1656937236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.897995\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2022.897995"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.897995","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2022,7,1]]},"article-number":"897995"}}